- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02368626
Safety and Efficacy of the EndyMed Pro System Using RF Micro-needles Fractional Skin Remodeling
February 20, 2015 updated by: EndyMed
Evaluation of the Safety and Efficacy of the EndyMed Pro™ System Using Radiofrequency (RF) Micro-needles Fractional Skin Remodeling Handpiece (Intensif) for Wrinkle Reduction and Lifting - a Post Marketing Study
The need for cosmetic facial enhancement procedures with minimal down time and low risk has led to the development of methods for non-surgical skin rejuvenation.
Various ablative lasers were developed, which remove the full skin surface in a controlled manner.
However, the prolonged recovery and the significant risks prompted the development of fractional lasers which ablate the skin in a fractional manner, leaving untreated areas to improve healing process.
In the past few years, fractional RF systems have been introduced that enable controlled skin resurfacing accompanied with dermal collagen remodeling.
System using focused ultrasound , coagulating small volume of tissue in the dermis , have shown a lifting effect.8
Similar to these devices the EndyMed Pro™ System with RF Micro-Needles handpiece (INTENSIF) enables fractional skin coagulation with dermal heating for the reduction of wrinkles together with a lifting effect.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
48
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hanna Levy, Dr
- Phone Number: +972-52-2824966
- Email: hanna@qsitemed.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
35 years to 60 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy patients age 35-60 with facial condition as required by the treatment.
- Subjects with Fitzpatrick elasticity level of 4 and above
- Subject able to comprehend and sign informed consent for participation in this study.
- Subject must commit to all treatments and follow-up visits.
- Subjects must approve the use of their B&A photos by the doctor and EndyMed
Exclusion Criteria:
- Subjects with implanted pacemakers, arrhythmias or any other electronic implanted device or severe known heart disorder
- Subjects with any implantable metal device in the treatment area.
- Subjects on any medication that would affect the characteristic of the skin (medical or hormonal), such as "Accutane", within the past 3 months.
- Subjects that have had any other invasive or noninvasive method of skin therapy hair removal, filers or Botox, performed in the past 3 months (in the treated area).
- Subjects who are scheduled or planned for any other invasive or noninvasive method of skin therapy in the treatment area at the period of the study.
- Subjects who have any form of suspicious lesion on the treatment area.
- Subjects with hypertrophic scarring, keloids, abnormal wound healing, as well as very dry and fragile skin.
- Pregnant or lactating Subjects.
- Subjects with Epilepsy or severe migraines.
- Subjects with permanent makeup/ tattoo/ body piercing (in the treated area).
- Subjects with any Infection / abscess / pains in treatment target area.
- History of any kind of cancer
- Any active condition in the treatment area, such as sores, psoriasis, eczema, and rash.
- Impaired immune system due to immunosuppressive diseases such as AIDS and HIV, or use of immunosuppressive medications.
- Patients with history of diseases stimulated by heat, such as recurrent Herpes Simplex in the treatment area, may be treated only following a prophylactic regime.
- Any surgical procedure in the treatment area within the last 3 months or before complete healing.
- Excessively tanned skin from sun, tanning beds or tanning creams within the last two weeks.
- Treating over the thyroid, breast or any other sensitive area.
- Subjects who suffer from autoimmune disorders or diabetes.
- Subjects using blood thinning medications.
- Subjects with clotting disorders.
- Subjects on drugs or psychologically determined unsuitable for the study.
- Subject is suffering extreme general weakness.
- Subject objects to the study protocol or unwilling to sign a consent form. Concurrent participation in any other clinical study.
- Any other condition that exclude the patient from the evaluation according to the physician judgment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: RF ablation treatment
'EndyMed Pro™ RF Micro-Needles' - RF ablation treatments for wrinkle appearance reduction
|
RF Micro-needles ablation treatments
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To evaluate the safety of the EndyMed ProTM Intensif handpiece for wrinkle reduction and lifting, measured by Adverse events occurrence
Time Frame: 5 months
|
Adverse events occurrence
|
5 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To evaluate the efficacy of the EndyMed ProTM Intensif handpiece for wrinkle reduction and lifting, measured by wrinkle appearance reduction
Time Frame: 5 months
|
wrinkle appearance reduction
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michael Gold, Dr, Tennessee Clinical Research Center, Nashville, Tennessee, USA
- Principal Investigator: Mark Taylor, Dr, Gateway Aesthetic Institute and Laser Center, Salt Lake City, Utah, USA
- Principal Investigator: Kenneth Rothaus, Dr, Ageless Plastic Surgery, New York, NY, USA
- Principal Investigator: Yohei Tanaka, Dr, Clinica Tanaka Plastic and Reconstructive Surgery and Anti-aging Center, Tokyo, Japan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Anticipated)
November 1, 2015
Study Completion (Anticipated)
January 1, 2016
Study Registration Dates
First Submitted
February 15, 2015
First Submitted That Met QC Criteria
February 20, 2015
First Posted (Estimate)
February 23, 2015
Study Record Updates
Last Update Posted (Estimate)
February 23, 2015
Last Update Submitted That Met QC Criteria
February 20, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- EM-FR-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting